Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.

Name: Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency.
Author: Jørgensen, S F

Rifaximin alters gut microbiota profile, but does not affect systemic inflammation - a randomized controlled trial in common variable immunodeficiency. — المؤلف: Jørgensen, S F — Scientific reports 20200511

المؤلف: Jørgensen, S F
النشر: Scientific reports 20200511
الوصف: 167 p.
الموضوعات: Adolescent؛ Adult؛ Aged؛ Anti-Bacterial Agents؛ Biomarkers؛ Common Variable Immunodeficiency؛ Dysbiosis؛ Female